IMPACT OF LONG-TERM ORAL ANTIVIRAL (OAV) TREATMENT ON HEPATOCELLULAR CARCINOMA (HCC) RISK IN IMMUNE-TOLERANT AND IMMUNE-ACTIVE CHRONIC HEPATITIS B PATIENTS (CHB) UTILIZING AMAP, A RECENTLY VALIDATED RISK PREDICTION TOOL
Chan, Henry Lik Yuen; Lim, Young-Suk; Hou, JinLin; Hui, Aric Josun; Seto, Wai-Kay; Chang, Ting-Tsung; Chuang, Wan-Long; Janssen, Harry L. A.; Fung, Scott K.; Ning, Qin; Izumi, Namiki; Flaherty, John F.; Suri, Vithika; Wang, Hongyuan; Manukyan, Avet; Shen, Sophie; Temme, Lauren; Osinusi, Anu O.; Agarwal, Kosh; Buti, Maria; Gane, Edward J.南方医科大学